The American Association for Cancer Research is accepting applications for its AACR-Bayer Innovation and Discovery Grants program, which is designed to provide new treatment options for cancers with high unmet medical need, encourage innovation and translation of ideas from basic research into novel drugs, and foster collaborations between excellent academic groups and the pharmaceutical industry.
The program offers one-year grants of $25,000 to meritorious projects that examine novel (and druggable) targets and biomarkers.
At the start of the grant term on October 1, applicants must hold a full-time mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent; have completed his or her most recent doctoral degree within the past five years (i.e., degree cannot have been conferred before October 2, 2011); and be working under the auspices of a mentor at an academic, medical, or research institution anywhere in the world. If eligibility is based on a future position, the position must be confirmed at the time of application and cannot be contingent upon receiving the grant.
In order to be eligible for this opportunity, applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in a related field and currently not be a candidate for a further doctoral or professional degree.
Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical, or research institution within North America.
See the AACR website for complete program guidelines and application instructions.